drugset / Trial / NCT00504530
r-hLIF for Improving Embryo Implantation in IVF
RandomizedParallel-groupDouble-blindTreatment
Summary
This study was designed to obtain pilot clinical evidence of the efficacy, safety and acceptability of r-hLIF administered during the luteal phase after IVF/intra-cytoplasmic sperm injection (ICSI) and ET for improving embryo implantation in infertile women with a history of at least three implantation failures following ART. Based on LIF expression patterns and experimental data from animal research a role of LIF in embryo implantation is anticipated.
Timeline
- Start
- 2001-09
- Primary completion
- —
- Completion
- 2002-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Emfilermin | Protein / enzyme biologic | — | — |
Indications
No indication recorded.